Analyses of 14-3-3 protein in the cerebrospinal fluid in Creutzfeldt-Jakob disease. Preliminary report;Badania białka 14-3-3 w płynie mózgowo-rdzeniowym w chorobie Creutzfeldta-Jakoba. Doniesienie wstepne

Neurologia i Neurochirurgia Polska

Volumn 39, Issue 5, 2005, Pages 358-365

  Golańska, Ewa ^a   Hułas Bigoszewska, Krystyna ^a   Sikorska, Beata ^a   Liberski, Paweł P ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

14 3 3 protein; Cerebrospinal fluid; Creutzfeldt Jakob disease; Diagnostic test

Indexed keywords

BIOCHEMICAL MARKER; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROTEIN 14 3 3; PROTEIN ANTIBODY;

ALCOHOL ABUSE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTAMINATION; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC ACCURACY; ERYTHROCYTE; FREEZE DRYING; HUMAN; NEUROPATHOLOGY; NON INVASIVE MEASUREMENT; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN DETERMINATION; RELIABILITY; WESTERN BLOTTING; WORLD HEALTH ORGANIZATION;

14-3-3 PROTEINS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CEREBROSPINAL FLUID; CREUTZFELDT-JAKOB SYNDROME; DIAGNOSIS, DIFFERENTIAL; HUMANS; PRIONS; REFERENCE VALUES;

EID: 28244497295     PISSN: 00283843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Green A.J.E., Thompson E.J., Stewart G.E. i wsp. Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2001; 70: 744-748.
2. Will R.G., Zeidler M., Stewart G.E. i wsp. Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol 2000; 47: 575-582.
3. Will R. Variant Creutzfeldt-Jakob disease. Folia Neurapathol 2004; 42 Suppl A: 77-83.
4. Green A.J.E. Use of 14-3-3 in the diagnosis of Creutzfeldt-Jakob disease. Biochem Soc Trans 2002; 30: 382-386.
5. Otto M., Wiltfang J., Tumani H. i wsp. Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci Lett 1997; 225: 210-212.
6. Beaudry P., Cohen P., Brandel J.P. i wsp. 14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord 1999; 10: 40-46.
7. Otto M., Stein H., Szudra A. i wsp. S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurol 1997; 244: 566-570.
8. Kropp S., Zerr I., Schulz-Schaeffer W.J. i wsp. Increase of neuron-specific enolase in patients with Creutzfeldt-Jakob disease. Neurosci Lett 1999; 261: 124-126.
9. Fu H., Subramanian R.R., Masters S.C. 14-3-3 proteins: structure, function, and regulation. Anna Rev Pharmacol Toxicol 2000; 40: 617-647.
10. Aitken A., Collinge D.B., van Heusden B.P. i wsp. 14-3-3 proteins: a highly conserved, widespread family of eukaryotic proteins. Trends Biochem Sci 1992; 17: 498-501.
11. Boston P.F., Jackson P., Thompson R.J. Human 14-3-3 protein: radioimmunoassay, tissue distribution, and cerebrospinal fluid levels in patients with neurological disorders. J Neurochem 1982; 38: 1475-1482.
12. Geschwind M.D., Martindale J., Miller D. i wsp. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol 2003; 60: 813-816.
13. Van Everbroeck B., Dobbeleir I., De Waele M. i wsp. Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients. J Neurol 2004; 251: 298-304.
14. Huang N., Marie S.K., Livramento J.A. i wsp. 14-3-3 protein in the CSF of patients with rapidly progressive dementia. Neurology 2003; 61: 354-357.
15. Zerr I., Schultz-Schaeffer W.J., Giese A. i wsp. Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants. Ann Neurol 2000; 48: 323-329.
16. Green A.J. Cerebrospinal fluid brain-derived proteins in the diagnosis of Alzheimer's disease and Creutzfeldt-Jakob disease. Neurapathol Appl Neurobiol 2002; 28: 427-440.
17. Irani D.N., Kerr D.A. 14-3-3 protein in the cerebrospinal fluid of patients with acute transverse myelitis. Lancet 2000; 355: 901.
18. Finsterer J., Voigtlander T. Elevated 14-3-3 protein and axonal loss in immunoglobulin-responsive, idiopathic acute transverse myelitis. Clin Neurol Neurosurg 2002; 105: 18-22.
19. Satoh J., Yukitake M., Kurohara K. i wsp. Detection of the 14-3-3 protein in the cerebrospinal fluid of Japanese multiple sclerosis patients presenting with severe myelitis. J Neurol Sci 2003; 212: 11-20.
20. Saiz A., Graus F, Dalmau J. i wsp. Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders. Ann Neurol 1999; 46: 774-777.
21. Colucci M., Roccatagliata L., Capello E. i wsp. The 14-3-3 protein in multiple sclerosis: a marker of disease severity. Mult Scler 2004; 10: 477-481.
22. Donahue J.E., Hanna P.A., Hariharan S. Autopsy-proven Creutzfeldt-Jakob disease in a patient with a negative 14-3-3 assay and nonspecific EEG and MRI. Neurol Sci 2004; 24: 411-413.
23. Mendez O.E., Shang J., Jungreis C.A. i wsp. Diffusion-weighted MRI in Creutzfeldt-Jakob disease: a better diagnostic marker than CSF protein 14-3-3? J Neuroimaging 2003; 13: 147-451.
24. Kenney K., Brechtel C., Takahashi H. i wsp. An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patients. Ann Neurol 2000; 48: 395-398.
25. Leuck J., Peoch K., Laplanche J.L. i wsp. A novel binding assay for detection of 14-3-3 protein in cerebrospinal fluid from Creutzfeldt-Jakob patients. Cell Mol Biol 2000; 46: 1291-1296.
26. Otto M., Wiltfang J. Differential diagnosis of neurodegenerative diseases with special emphasis on Creutzfeldt-Jakob disease. Restor Neurol Neurosci 2003; 21: 191-209.
27. Van Everbroeck B., Quoilin S., Boons J. i wsp. A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2003; 74: 1210-1214.
28. Van Everbroeck B., Green A.J. Vanmechelen E. i wsp. Phosphorylated tau in cerebrospinal fluid as a marker for Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2002; 73: 79-91.
29. Otto M., Wiltfang J., Cepek L. i wsp. Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 2002; 58: 192-197.
30. Green A.J., Harvey R.J., Thompson E.J. i wsp. Increased S100β in the cerebrospinal fluid of patients with frontotemporal dementia. Neurosci Lett 1997; 235: 5-8.
31. Green A.J.E., Keir G., Thompson E.J. A specific and sensitive ELISA for measuring S-100b in cerebrospinal fluid. J Immunol Methods 1997; 205: 35-41.
32. Bartosik-Psujek H., Archelos J.J. Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG. J Neurol 2004; 251: 414-420.
33. Hilton D.A., Sutak J., Smith M.E. i wsp. Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. J Clin Pathol 2004; 57: 300-302.